MannKind Corp. (MNKD) News Headlines

▮ More

Date

Headline

5/17/2022 6:25:33 AM MannKind Corp. To Acquire V-Go From Zealand Pharma - Quick Facts

5/17/2022 6:17:25 AM MannKind Enters Deal To Acquire V-Go Insulin Delivery Device From Zealand Pharma

5/5/2022 5:13:11 PM MannKind Corp. Q1 loss increases in line with estimates

5/5/2022 3:00:40 PM MannKind Q1 22 Earnings Conference Call At 5:00 PM ET

2/24/2022 4:57:48 PM MannKind Corp. Loss at -$28.06 Mln in Q4

2/24/2022 3:02:34 PM MannKind Q4 21 Earnings Conference Call At 5:00 PM ET

11/9/2021 4:35:25 PM MannKind Corp. Q3 adjusted earnings Beat Estimates

11/9/2021 6:00:20 AM MannKind Q3 21 Earnings Conference Call At 5:00 PM ET

10/4/2021 7:06:44 AM MannKind Enrolls First Patient Enrolled In Inhale-1 Study Of Afrezza® In Pediatric Population

9/7/2021 6:02:47 AM United Therapeutics Presents Tyvaso DPI BREEZE Clinical Data At European Respiratory Society International Congress 2021

8/11/2021 5:41:42 PM MannKind Corp. Q2 adjusted earnings Miss Estimates

8/11/2021 6:15:08 AM MannKind Q2 21 Earnings Conference Call At 5:00 PM ET

8/4/2021 7:50:28 AM MannKind Partners With NRx Pharma To Explore Dry Powder Formulation Of ZYESAMI

8/4/2021 6:54:10 AM MannKind Partners With NRx Pharm To Explore Dry Powder Formulation Of ZYESAMI Based On Technosphere Platform

6/16/2021 12:12:46 PM MannKind Says FDA Grants Priority Review For Tyvaso DPI NDA

6/16/2021 11:02:35 AM MannKind : FDA Accepts For Priority Review Of NDA For Tyvaso DPI For Treatment Of PAH And PH-ILD

6/3/2021 6:03:41 AM MannKind Presents A Post Hoc Analysis From STAT Study

4/19/2021 7:11:25 AM United Therapeutics Files New Drug Application For Tyvaso DPI- Quick Fats

4/19/2021 6:08:32 AM MannKind, United Therapeutics Reach Milestone In Development Of Tyvaso DPI

3/2/2021 6:36:16 AM MannKind Prices Upsized $200.0 Mln Convertible Senior Notes Offering

Mannkind Corp. (MNKD)